The US FDA recently gave green signal to market IDx-DR, a medical device to detect diabetic retinopathy, a disease in which high blood sugar damages blood vessels in the retina of eyes and leads to the vision loss.

Close to 90 health activists, patient groups and individuals workingtowards the elimination of tuberculosis have called upon Prime MinisterNarendra Modi to make drug resistant TB (DR-TB) drugs affordable byensuring supply of generic drugs

An exponential leap in processing power is around the corner, but will we use or abuse it?

Zee Entertainment MD Punit Goenka has always been sceptical about offering content free. The home-grown media conglomerate earlier this week let out its digital strategy with the launch of Zee 5.

Watch BusinessToday.in Editor Rajeev Dubey talk to Dr. Ben Feringa, Organic Chemist and Nobel Laureate on discovery of new drugs, Indian pharmaceutical companies penalised by FDA and the challenges faced by Indian pharma companies.

With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.

Many companies, with some leading players, are already coping with challenges around price erosion in generics, erosion of base business resulting from new competition and buyer consolidation in their biggest global market, the US.

Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.

Certain pharma industry leaders point out that the draft of new pharmaceutical policy has been written in an amateurish manner.

N. Chandrasekaran is doing his best to restore normalcy at the Tata Group after the acrimonious exit of Cyrus Mistry. But his problems are many.

India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients.

With presence in over 100 countries, India being one of its key geographies, the foundation aims to help find solutions to reduce extreme poverty and improve health.

Apex think tank Niti Aayog has proposed a change in the manner the government identifies medicines that should be brought under price control.

A group of inheritors takes charge with new ideas and new strategies